TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumab.

Alan B Sandler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.